1.Fahal, A et al. (2015) Mycetoma in the Sudan: an update from the Mycetoma Research Centre, University of Khartoum, Sudan. PLoS Neglected Tropical Diseases 9, e0003679. doi: 10.1371/journal.pntd.0003679.
2.Zijlstra, EE et al. (2016) Mycetoma: a unique neglected tropical disease. Lancet Infectious Diseases 16, 100–112.
3.Desnos-Ollivier, M et al. (2006) Molecular identification of black-grain mycetoma agents. Journal of Clinical Microbiology 44, 3517–3523.
4.Singh, H et al. (1979) Mycetoma in India. Indian Journal of Surgery 41, 577–597.
5.Mathur, DR et al. (1979) An etiological and pathological study of mycetoma in Western Rajasthan. Current Medicine Research and Practice 23, 151–161.
6.Rippon, JW et al. Medical Mycology: The Pathogenic Fungi and the Pathogenic Actinomycetes. Philadelphia: WB Saunders Co., pp. 1–797.
7.Mattioni, S et al. (2013) Management of mycetomas in France. Medecine et Maladies Infectieuses 43, 286–294.
8.Desai, SC et al. (1970) Clinical, mycological, histological and radiological studies on 40 cases of mycetomas with a note on its history and epidemiology in India. Indian Journal of Surgery 32, 427–444.
9.Reddy, CRRM et al. (1972) Mycetoma – histological diagnosis of causal agents in 50 cases. Indian Journal of Medical Sciences 26, 733–736.
10.Fahal, A et al. (2014) A new model for management of mycetoma in the Sudan. PLoS Neglected Tropical Diseases 8, e3271.
12.Mencarini, J et al. (2016) Madura foot in Europe: diagnosis of an autochthonous case by molecular approach and review of literature. New Microbiology 39, 156–159.
13.Welsh, O et al. (2007) Mycetoma. American Journal of Clinical Dermatology 25, 195–202.
14.van de Sande, WW et al. (2014) Merits and pitfalls of currently used diagnostic tools in mycetoma. PLoS Neglected Tropical Diseases 8, e2918.
15.Zijlstra, EE et al. (2016) Mycetoma. Lancet Infectious Diseases 16, 100–112.
16.Fahal, AH (2004) Mycetoma thorn on the flesh. Transactions of the Royal Society of Tropical Medicine and Hygiene 98, 3–11.
17.Fahal, AH and Hassan, MA (1992) Mycetoma. British Journal of Surgery 79, 1138–1141.
18.Zein, HAM et al. (2012) The predictors of cure, amputation & follow-up dropout among mycetoma patients as seen at the Mycetoma Research Centre, University of Khartoum. Transactions of the Royal Society of Tropical Medicine and Hygiene 106, 639–644.
19.Castro, LGM et al. (2008) Clinical and mycological findings and therapeutic outcome of 27 mycetoma patients from Sao Paulo, Brazil. International Journal of Dermatology 47, 160–163.
20.Venkatswami, S, Sankarasubramanian, A and Subramanyam, S (2012) The Madura foot: looking deep. International Journal of Low Extremity Wounds 11, 31–42.
21.Sampaio, FM et al. (2013) Eumycetoma by Madurella mycetomatis with 30 years of evolution: therapeutic challenge. Anais Brasileiros de Dermatologia 88, 82–84.
22.Bakshi, R and Mathur, DR (2008) Incidence and changing pattern of mycetoma in Western Rajasthan. Indian Journal of Pathology and Microbiology 51, 154–155.
23.Maiti, PK et al. (1998) Mycetomas in exposed and nonexposed parts of the body: a study of 212 cases. Indian Journal of Medical Microbiology 16, 19–22.
24.Dieng, MT et al. (2003) Mycetoma: 130 cases. Annals De Dermatologie Et De Venereologie 130, 16–19.
25.Bonifaz, A et al. (2014) Mycetoma: experience of 482 cases in a single center in Mexico. PLoS Neglected Tropical Disease 8, 31.
26.Hassan, MA and Fahal, AH. (2004) Mycetoma. In Kamil, R and Lumby, J (eds), Tropical Surgery. London, UK: Westminster Publications, pp. 786–790.
27.Lupi, O, Tyring, SK and McGinnis, MR (2005) Tropical dermatology: fungal tropical diseases. Journal of the American Academy of Dermatology 53, 931–951.
28.Fahal, AH. (2006) Mycetoma: Clinico–Pathological Monograph. Khartoum, Sudan: University of Khartoum Press, vol. 10, pp. 59–70.
29.Ahmed, AO et al. (2004) In vitro susceptibilities of Madurella mycetomatis to itraconazole and amphotericin B assessed by a modified NCCLS method and a viability-based 2,3-Bis(2-methoxy-4-nitro-5-sulfophenyl)-5-cotrimoxazole(phenylamino)carbonyl-2H-tetrazolium hydroxide (XTT) assay. Antimicrobial Agents Chemotherapy 48, 2742–2746.
30.van de Sande, WW et al. (2007) In vitro susceptibility of Madurella mycetomatis, prime agent of Madura foot, to tea tree oil and artemisinin. Journal of Antimicrobial Chemotherapy 59, 553–555.
31.van de Sande, WW et al. (2007) Melanin biosynthesis in Madurella mycetomatis and its effect on susceptibility to itraconazole and ketoconazole. Microbes and Infection 9, 1114–1123.
32.Emmanuel, P et al. (2018) Mycetoma: a clinical dilemma in resource limited settings. Annals of Clinical Microbiology and Antimicrobials 17, 35.
33.Abbas, M et al. (2018) The disabling consequences of Mycetoma. PLoS Neglected Tropical Disease 12, e0007019.